文献速递骨质疏松与钙磷/甲状旁腺

G蛋白亚基α11功能缺失性Thr347Ala变异导致家族性低尿钙性高钙血症2型

Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在一个家族中鉴定出杂合GNA11 Thr347Ala变异,携带者表现为轻度无症状高钙血症、低尿钙及不适当正常PTH水平。体外IP1蓄积实验显示该变异使钙在CaSR的激动剂效力中度但显著降低,EC50为5.67 mM对4.38 mM。该新变异证实Gα11对CaSR信号和钙稳态的重要作用。

要点

  • GNA11 Thr347Ala杂合携带者表现为轻度无症状高钙血症、低尿钙和不适当正常PTH。
  • 该变异不影响Gα11表达或CaSR细胞表面表达。
  • IP1蓄积实验中钙对CaSR/Gα11-Thr347Ala的激动剂效力较野生型降低,EC50为5.67 mM对4.38 mM。

核心结论

  • 该新型GNA11变异导致FHH2,证实Gα11对CaSR信号和钙稳态的重要作用。

研究设计与样本

  • 鉴定一个携带杂合GNA11 Thr347Ala变异的家族,对先证者及其家属进行临床、生化和遗传学分析。
  • 在共转染CaSR与Gα11(野生型或Thr347Ala)的人胚胎肾293A Gq/11敲除细胞(ΔGq/11-HEK293A)中测定Gα11表达水平和CaSR细胞表面表达水平,并用肌醇单磷酸(IP1)蓄积实验表征钙在CaSR的功能特性。

主要发现

  • GNA11 Thr347Ala杂合携带者具有轻度无症状高钙血症、低尿钙,以及考虑其血清钙升高情况下不适当正常PTH水平。
  • 该变异不影响Gα11表达或CaSR细胞表面表达水平。
  • IP1蓄积实验中,钙对CaSR/Gα11-Thr347Ala转染细胞的激动剂效力中度但显著低于CaSR/Gα11-WT转染细胞,EC50分别为5.67 mM和4.38 mM。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT AND OBJECTIVES: To date, only 4 loss-of-function variants in the GNA11 gene encoding the G protein subunit α11 (Gα11) leading to familial hypocalciuric hypercalcemia (FHH) 2 have been characterized. Gα11 is involved in calcium-sensing receptor (CaSR) signaling, and loss-of-function variants in GNA11 lead to reduced agonist potency at CaSR and an FHH phenotype. DESIGN AND PARTICIPANTS: We have identified a family with a heterozygous GNA11 Thr347Ala variant and characterized its impact on calcium homeostasis in FHH2 patients and the signaling properties of CaSR through the Gα11-Thr347Ala variant in vitro. MAIN OUTCOME MEASURES: The index patient and her family had clinical, biochemical, and genetic analyses performed. The expression levels of Gα11 and the cell-surface expression levels of CaSR in human embryonic kidney 293A Gq/11 knockout cells (ΔGq/11-HEK293A) cotransfected with CaSR and Gα11 [wild type (WT) or Thr347Ala] were determined, and the functional properties exhibited by calcium at CaSR were characterized in an inositol monophosphate (IP1) accumulation assay. RESULTS: Heterozygous carriers of the GNA11 Thr347Ala variant had mild asymptomatic hypercalcemia, hypocalciuria, and inappropriately high normal PTH levels considering their elevated serum calcium levels. Whereas the variant did not impact Gα11 expression or CaSR cell surface expression levels, calcium displayed a moderately but significantly lower agonist potency at CaSR/Gα11-Thr347Ala-transfected cells compared with CaSR/Gα11-WT-transfected cells in the IP1 accumulation assay (EC50 values of 5.67 mM and 4.38 mM, respectively). CONCLUSION: This identification of a novel GNA11 variant causing FHH2 substantiates the important role of Gα11 for CaSR signaling and Ca2+ homeostasis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Boisen IM, Du W, Juul A, et al. Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2. J Clin Endocrinol Metab. 2025. PMID: 38920275. doi:10.1210/clinem/dgae440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。